Perkin Elmer and BIF collab to help train local businesses

The Biomanufacturing Immersion Facility (BIF) in collaboration with PerkinElmer have established a training facility to assist local biotech companies and academia to have access to the PerkinElmer’s LabChip® technology. The facility acts as a centre for demonstrations, method development, and training.

In June, NeuClone, a Sydney based biotherapeutic company, received training on the LabChip GX II Touch instrument and software, while they waited upon delivery of their newly purchased instrument.  Training at the facility ensured that once their instrument arrived critical work could commence.  Further access would also be allowed to support NeuClone’s ongoing pre- and early clinical programs.

“(Being) able to access the LabChip instrument at BIF provides NeuClone with back-up capabilities in our research and development operations while the installation and qualification of our recently purchased LabChip GX II Touch are in progress” said Dr Angelo Perani, the Chief Scientific Officer of NeuClone.

“The partnership with BIF plays an important role in ensuring excellent customer support through industry and academic collaboration” said Tony Bhalla, Perkin Elmer’s Oceania sales and service leader - Diagnostics & LifeSciences.

BIF currently delivers the world’s best practice training in bioprocessing by delivering licensed teaching and training curriculum from the industry-renowned National Institute for Bioprocessing Research and Training (NIBRT) facility in Ireland. Partnerships with industry vendors to provide post-purchase-pre-delivery access and training programs present an innovative way to expand BIF’s training and teaching role to further support local bio-industry partners, SMEs, and academia with their research and business.

Links

• Biologics Innovation Facility at UTS
• NeuClone
• Perkin Elmer